Mrs Megan Marie Luke, PHARM D in Albany, MO - Pharmacist

Mrs Megan Marie Luke, PHARM D is a Pharmacist based in Albany, Missouri. Mrs Megan Marie Luke is licensed to practice in Missouri (license number 2018025580) and her current practice location is 703 E Us Highway 136, Albany, Missouri. She can be reached at her office (for appointments etc.) via phone at (660) 822-0090.

NPI number for Mrs Megan Marie Luke is 1164020202 and her current mailing address is 703 E Us Highway 136, Albany, Missouri. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1164020202.

Contact Information

	Mrs Megan Marie Luke, PHARM D
	703 E Us Highway 136, Albany, MO 64402-8209
	(660) 822-0090
	(660) 822-0089

Healthcare Provider's Profile

Full Name	Mrs Megan Marie Luke
Gender	Female
Speciality	Pharmacist
Location	703 E Us Highway 136, Albany, Missouri
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1164020202
Provider Enumeration Date: 10/12/2020
Last Update Date: 10/12/2020

Medical Identifiers

Medical identifiers for Mrs Megan Marie Luke such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1164020202	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	2018025580 (Missouri)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Megan Marie Luke is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Megan Marie Luke, PHARM D 703 E Us Highway 136, Albany, MO 64402-8209 Ph: (660) 822-0090	Mrs Megan Marie Luke, PHARM D 703 E Us Highway 136, Albany, MO 64402-8209 Ph: (660) 822-0090

News Archive

Duke receives approval to initiate NPC-1C Phase I trial for advanced pancreatic and colorectal cancer

Neogenix Oncology, Inc. announced today that researchers at Duke University Medical Center have received approval to move forward with a Phase I trial of the company's lead therapeutic antibody, NPC-1C, in patients with advanced stage pancreatic or colorectal cancer. Duke joins Johns Hopkins Hospital which is already conducting the Phase I trial of NPC-1C. In addition to Johns Hopkins, North Shore - LIJ has also enrolled patients on this multi-center study.

New therapeutic approach for Parkinson's and other neurodegenerative diseases

Xiang-Dong Fu, PhD, has never been more excited about something in his entire career. He has long studied the basic biology of RNA, a genetic cousin of DNA, and the proteins that bind it. But a single discovery has launched Fu into a completely new field: neuroscience.

NCATS funds collaboration initiative aimed at repurposing antimalarial to combat Ebola virus

The National Center for Advancing Translational Sciences recently awarded $596,533.00 to Collaborations Pharmaceuticals, Inc. to initiate a partnership with Texas Biomedical Research Institute aimed at repurposing an antimalarial for use against the Ebola virus.

Alzheimer's preclinical staging criteria supported

The Alzheimer's disease preclinical staging criteria proposed by the National Institute on Aging and the Alzheimer's Association appear to be valid over more than a decade of follow-up, say researchers.

HHS limits Obamacare options for small businesses

A final rule released Friday confirms that a provision of the health law aimed at helping small businesses provide insurance to their employees will be limited until 2015.

Mrs Megan Marie Luke, PHARM D - Pharmacist in Albany, MO